Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon

Active Cooperative Agreement Awarded Last action

Award ID
U01CA301988
Recipient
Awarding agency
Obligated
$988,913

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date 43% complete
Place of performance
Boston, MA 02114, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $114,000
Amendment $233,405
Original award $641,508

Subawards

Subrecipient Amount Awarded
Monash University Dr. Wolfe is Professor of Biostatistics in the School of Public Health and Preventive Medicine at Monash University, and has vast experience in… $364,000
Hennepin Healthcare Research Institute ASPREE-LT will study the long-term effects of aspirin and other factors on the health of older persons as an extension of the ASPREE clinic study and the… $77,425

Quick answers

Who received award U01CA301988?

U01CA301988 was awarded to The General Hospital Corporation by National Cancer Institute (National Institutes of Health) on September 26, 2024.

How much is award U01CA301988 worth?

$988,913 has been obligated on U01CA301988.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login